• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚阿达玛市直接观察短期治疗方案下结核病治疗结果的决定因素。

Determinants of tuberculosis treatment outcome under directly observed treatment short courses in Adama City, Ethiopia.

机构信息

Tuberculosis and Leprosy Control and Prevention unit, Oromia Health Bureau, Addis Ababa, Ethiopia.

Department of Public Health, Institute of Health Sciences, Wollega University, Nekemte, Ethiopia.

出版信息

PLoS One. 2020 Apr 29;15(4):e0232468. doi: 10.1371/journal.pone.0232468. eCollection 2020.

DOI:10.1371/journal.pone.0232468
PMID:32348358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190142/
Abstract

BACKGROUND

Tuberculosis (TB) is a leading cause of death among infectious agents, ranking above HIV/AIDS. Though much effort has been done, Ethiopia remained one of those countries which share the greatest burden of TB. Evaluating the TB treatment outcome is one method of TB control measures. Therefore, the aim of the current study was to assess TB treatment outcome and its determinants under directly observed treatment short courses in Adama City, Central Ethiopia.

METHOD

An institutional based cross sectional study was conducted in all public and private health facilities of Adama city from March 1st 2016 to December 31st, 2016. The data were entered and analyzed by using SPSS version 21.0 statistical software. The results were presented using descriptive statistics. Univariate and multivariate logistic regression model was used to evaluate the potential determinants of unsuccessful treatment outcome.

RESULTS

Among 281 patients evaluated, 90(32%) were cured, 137(48.8%) have completed the treatment, 4(1.4%) were treatment failure, 36(12.8%) were lost to follow up, and 14 (5%) died. The overall treatment success rate was 80.8%. Age 15-24 (Adjusted odds ratio (AOR): 4.97; 95% Confidence interval (CI): 1.13-21.90), distance less than 5 kilometers from treatment center (AOR: 3.1; 95% CI: 1.42-6.77), being seronegative for human immunodeficiency virus (HIV) (AOR: 20.38; 95% CI: 7.80-53.24) were associated with successful TB treatment outcome.

CONCLUSION

The treatment outcome of all forms tuberculosis patients in Adama city was unsatisfactory when referred with the national pooled estimate of 86% and WHO 2030 international target of ≥90%. Thus, enhancing client supervision, treatment monitoring; and working on provision TB treatment services at nearby health facilities should be a priority concern to improve the success rate of treatment outcome. Further studies are also recommended to explore important factors which were not examined by current study.

摘要

背景

结核病(TB)是传染病死亡的主要原因,排在艾滋病病毒/艾滋病之上。尽管已经做出了很多努力,但埃塞俄比亚仍然是结核病负担最重的国家之一。评估结核病治疗结果是结核病控制措施之一。因此,本研究旨在评估在埃塞俄比亚阿达玛市直接观察治疗短期疗程下的结核病治疗结果及其决定因素。

方法

2016 年 3 月 1 日至 2016 年 12 月 31 日,在阿达玛市所有公立和私立卫生机构进行了一项基于机构的横断面研究。数据由 SPSS 版本 21.0 统计软件输入和分析。结果采用描述性统计方法表示。采用单变量和多变量逻辑回归模型评估治疗结果不成功的潜在决定因素。

结果

在 281 例接受评估的患者中,90 例(32%)治愈,137 例(48.8%)完成治疗,4 例(1.4%)治疗失败,36 例(12.8%)失访,14 例(5%)死亡。总治疗成功率为 80.8%。年龄在 15-24 岁之间(调整优势比(AOR):4.97;95%置信区间(CI):1.13-21.90)、距离治疗中心小于 5 公里(AOR:3.1;95%CI:1.42-6.77)、人类免疫缺陷病毒(HIV)血清阴性(AOR:20.38;95%CI:7.80-53.24)与结核病治疗成功相关。

结论

当参照全国 86%的综合估计数和世卫组织 2030 年 90%的国际目标时,阿达玛市所有形式结核病患者的治疗结果并不令人满意。因此,加强对患者的监督、治疗监测,并在附近的卫生机构提供结核病治疗服务,应成为提高治疗成功率的优先事项。还建议进行进一步的研究,以探讨当前研究未检查的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abca/7190142/97ab2fe936ea/pone.0232468.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abca/7190142/2db69105ccec/pone.0232468.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abca/7190142/97ab2fe936ea/pone.0232468.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abca/7190142/2db69105ccec/pone.0232468.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abca/7190142/97ab2fe936ea/pone.0232468.g002.jpg

相似文献

1
Determinants of tuberculosis treatment outcome under directly observed treatment short courses in Adama City, Ethiopia.埃塞俄比亚阿达玛市直接观察短期治疗方案下结核病治疗结果的决定因素。
PLoS One. 2020 Apr 29;15(4):e0232468. doi: 10.1371/journal.pone.0232468. eCollection 2020.
2
Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.埃塞俄比亚西北部贡德尔大学转诊医院结核病/艾滋病合并感染患者的成功结核病治疗结果及其相关因素:一项基于机构的横断面研究。
BMC Infect Dis. 2017 Feb 8;17(1):132. doi: 10.1186/s12879-017-2238-7.
3
Profile of tuberculosis and its response to anti-TB drugs among tuberculosis patients treated under the TB control programme at Felege-Hiwot Referral Hospital, Ethiopia.埃塞俄比亚费莱格-希沃特转诊医院结核病控制项目下治疗的结核病患者的结核病概况及其对抗结核药物的反应
BMC Public Health. 2016 Aug 2;16:688. doi: 10.1186/s12889-016-3362-9.
4
Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia.与埃塞俄比亚甘贝拉地区难民及其周边社区的结核病患者治疗结果不佳相关的因素。
PLoS One. 2018 Oct 18;13(10):e0205468. doi: 10.1371/journal.pone.0205468. eCollection 2018.
5
Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study.埃塞俄比亚南部直接观察短程治疗下结核病患者的治疗结果及影响结果的因素:一项五年回顾性研究
PLoS One. 2016 Feb 26;11(2):e0150560. doi: 10.1371/journal.pone.0150560. eCollection 2016.
6
Treatment outcome of tuberculosis among Human Immunodeficiency Virus positive patients in Eastern Ethiopia: a retrospective study.埃塞俄比亚东部人类免疫缺陷病毒阳性患者的结核病治疗结果:一项回顾性研究。
Pan Afr Med J. 2018 May 16;30:32. doi: 10.11604/pamj.2018.30.32.12554. eCollection 2018.
7
Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega, Western Ethiopia.在埃塞俄比亚西部东沃洛格地区选定的卫生机构中,结核病患者的治疗效果不佳及其决定因素。
PLoS One. 2018 Oct 26;13(10):e0206227. doi: 10.1371/journal.pone.0206227. eCollection 2018.
8
Impact of HIV Status on Treatment Outcome of Tuberculosis Patients Registered at Arsi Negele Health Center, Southern Ethiopia: A Six Year Retrospective Study.HIV状态对埃塞俄比亚南部阿尔西内盖勒健康中心登记的结核病患者治疗结果的影响:一项六年回顾性研究。
PLoS One. 2016 Apr 20;11(4):e0153239. doi: 10.1371/journal.pone.0153239. eCollection 2016.
9
Tuberculosis patients' satisfaction with directly observed treatment short course strategy and associated factors in Southern Ethiopia: a mixed method study.南非结核病患者对直接观察短期治疗策略的满意度及其影响因素:一项混合方法研究。
BMC Public Health. 2024 Sep 9;24(1):2452. doi: 10.1186/s12889-024-19940-6.
10
Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study.哈勒尔市公立医院结核分枝杆菌/人类免疫缺陷病毒双重感染患者的治疗结局及其影响因素:一项为期五年的回顾性研究。
BMC Public Health. 2019 Dec 10;19(1):1658. doi: 10.1186/s12889-019-7980-x.

引用本文的文献

1
Tuberculosis treatment success rate and its predictors among TB HIV co-infected patients in East and North Eastern Uganda.乌干达东部和东北部结核病与艾滋病毒合并感染患者的结核病治疗成功率及其预测因素。
Sci Rep. 2025 Feb 14;15(1):5532. doi: 10.1038/s41598-024-85039-y.
2
Impact of HIV coinfection on tuberculosis treatment outcomes in Ethiopia: a systematic review and meta-analysis.艾滋病毒合并感染对埃塞俄比亚结核病治疗结局的影响:系统评价和荟萃分析。
BMJ Open. 2024 Jul 5;14(7):e087218. doi: 10.1136/bmjopen-2024-087218.
3
Tuberculosis treatment outcomes and associated factors at Alemgena Health Center, Sebeta, Oromia, Ethiopia.

本文引用的文献

1
Mapping tuberculosis treatment outcomes in Ethiopia.绘制埃塞俄比亚结核病治疗结果图谱。
BMC Infect Dis. 2019 May 28;19(1):474. doi: 10.1186/s12879-019-4099-8.
2
Tuberculosis Treatment Outcomes and Associated Factors among TB Patients Attending Public Hospitals in Harar Town, Eastern Ethiopia: A Five-Year Retrospective Study.埃塞俄比亚东部哈勒尔镇公立医院结核病患者的治疗结果及相关因素:一项五年回顾性研究
Tuberc Res Treat. 2019 Apr 1;2019:1503219. doi: 10.1155/2019/1503219. eCollection 2019.
3
Treatment outcomes and associated factors in tuberculosis patients at Jimma University Medical Center: A 5-year retrospective study.
埃塞俄比亚奥罗米亚州塞贝塔的阿勒根纳健康中心的结核病治疗结果和相关因素。
PLoS One. 2024 May 21;19(5):e0303797. doi: 10.1371/journal.pone.0303797. eCollection 2024.
4
Treatment outcomes of tuberculosis cases by HIV status in Haramaya General Hospital, Ethiopia: A retrospective cross-sectional study.埃塞俄比亚哈拉马亚综合医院按艾滋病毒感染状况划分的结核病病例治疗结果:一项回顾性横断面研究。
Medicine (Baltimore). 2024 May 3;103(18):e38034. doi: 10.1097/MD.0000000000038034.
5
Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta Town, Northwest Ethiopia: a five-year retrospective study.结核治疗结局及其相关因素分析:来自埃塞俄比亚西北莫塔镇医疗机构的五年回顾性研究。
Sci Rep. 2024 Apr 2;14(1):7695. doi: 10.1038/s41598-024-58080-0.
6
A comparative analysis of the profile and treatment outcomes of tuberculosis patients managed at the community and primary health care facilities in Botswana.博茨瓦纳社区和初级卫生保健机构中结核病患者的概况及治疗结果的比较分析。
J Clin Tuberc Other Mycobact Dis. 2023 Sep 26;33:100400. doi: 10.1016/j.jctube.2023.100400. eCollection 2023 Dec.
7
Evaluation of drug-resistant tuberculosis treatment outcome in Limpopo province, South Africa.南非林波波省耐药结核病治疗结局评价。
Afr J Prim Health Care Fam Med. 2023 Jul 31;15(1):e1-e7. doi: 10.4102/phcfm.v15i1.3764.
8
Tuberculosis Treatment Outcome and Associated Factors Among Tuberculosis Patients Linked to Tuberculosis Treatment Clinics in Ethiopia, 2023: A Multi-Center Retrospective Study.2023年埃塞俄比亚与结核病治疗诊所相关的结核病患者的治疗结果及相关因素:一项多中心回顾性研究
Infect Drug Resist. 2023 May 30;16:3367-3378. doi: 10.2147/IDR.S413272. eCollection 2023.
9
Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study.糖尿病与埃塞俄比亚药物敏感型肺结核患者治疗结果不佳的风险增加有关:一项基于医疗机构的前瞻性研究。
J Clin Tuberc Other Mycobact Dis. 2023 Apr 11;31:100368. doi: 10.1016/j.jctube.2023.100368. eCollection 2023 May.
10
Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study.埃塞俄比亚南部吉贝县成人肺结核治疗效果不佳及相关因素:一项基于机构的横断面研究。
PLOS Glob Public Health. 2022 Mar 10;2(3):e0000161. doi: 10.1371/journal.pgph.0000161. eCollection 2022.
吉马大学医学中心结核病患者的治疗结果及相关因素:一项5年回顾性研究
Int J Mycobacteriol. 2019 Jan-Mar;8(1):35-41. doi: 10.4103/ijmy.ijmy_177_18.
4
Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis.抗结核治疗不依从在埃塞俄比亚的流行情况及其决定因素:系统评价和荟萃分析。
PLoS One. 2019 Jan 10;14(1):e0210422. doi: 10.1371/journal.pone.0210422. eCollection 2019.
5
Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega, Western Ethiopia.在埃塞俄比亚西部东沃洛格地区选定的卫生机构中,结核病患者的治疗效果不佳及其决定因素。
PLoS One. 2018 Oct 26;13(10):e0206227. doi: 10.1371/journal.pone.0206227. eCollection 2018.
6
Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia.与埃塞俄比亚甘贝拉地区难民及其周边社区的结核病患者治疗结果不佳相关的因素。
PLoS One. 2018 Oct 18;13(10):e0205468. doi: 10.1371/journal.pone.0205468. eCollection 2018.
7
Drug-susceptible tuberculosis treatment success and associated factors in Ethiopia from 2005 to 2017: a systematic review and meta-analysis.2005年至2017年埃塞俄比亚药物敏感性结核病治疗成功率及相关因素:系统评价与荟萃分析
BMJ Open. 2018 Sep 25;8(9):e022111. doi: 10.1136/bmjopen-2018-022111.
8
Analysis of tuberculosis treatment outcomes among pulmonary tuberculosis patients in Bahawalpur, Pakistan.巴基斯坦巴哈瓦尔布尔肺结核患者的结核病治疗结果分析。
BMC Res Notes. 2018 Jun 8;11(1):370. doi: 10.1186/s13104-018-3473-8.
9
Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.2003 年至 2016 年埃塞俄比亚的结核病治疗结果,以及 HIV 合并感染和既往药物暴露的影响:系统评价和荟萃分析。
PLoS One. 2018 Mar 19;13(3):e0194675. doi: 10.1371/journal.pone.0194675. eCollection 2018.
10
Treatment Outcomes of Tuberculosis at Asella Teaching Hospital, Ethiopia: Ten Years' Retrospective Aggregated Data.埃塞俄比亚阿塞拉教学医院结核病的治疗结果:十年回顾性汇总数据
Front Med (Lausanne). 2018 Feb 21;5:38. doi: 10.3389/fmed.2018.00038. eCollection 2018.